Stock Events

Stock Events

Genelux

$2.42

0

+$0+0% Monday 02:44

Statistics

Day High

2.42

Day Low

2.42

52W High

-

52W Low

-

Volume

13

Avg. Volume

-

Mkt Cap

92.09M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

13MayExpected

Q3 2025

Q4 2025

Next

-0.24

-0.23

-0.21

-0.2

Expected EPS

-0.195

Actual EPS

N/A

Financials

-373,362.5%Profit Margin

Unprofitable

2021

2022

2023

2024

16,000Revenue

-59.74MNet Income

Analyst Ratings

18Average Price Target

The highest estimate is 20.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.

Buy

50%

Hold

50%

Sell

0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNLX.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Amgen is a biotechnology company that develops innovative therapeutics, including in oncology, which competes with Genelux's focus on cancer treatment.

Merck is a global healthcare company that produces cancer drugs and vaccines, directly competing with Genelux's cancer therapies.

Bristol-Myers Squibb

Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines for cancer, competing in the same therapeutic area as Genelux.

Pfizer is a pharmaceutical corporation with a broad portfolio that includes oncology products, competing with Genelux's cancer-focused therapies.

Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops and markets therapies in areas including oncology, competing with Genelux's cancer treatments.

Novartis is a global healthcare company with a strong emphasis on research and development in oncology, making it a competitor to Genelux.

Roche Holding AG is a leader in oncology drugs and personalized medicine, directly competing with Genelux's approach to cancer treatment.

AstraZeneca is a biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines, including for cancer, competing with Genelux.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is involved in developing and commercializing medicines for serious medical conditions, including oncology, competing with Genelux.

About

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.

Show more...

CEO

ISIN

US36870H1032

Listings

0 Comments

Share your thoughts

FAQ

What is Genelux stock price today?▼

The current price of GNLX.BOATS is $2.42 USD — it has increased by +0% in the past 24 hours. Watch Genelux stock price performance more closely on the chart.

What is Genelux stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Genelux stocks are traded under the ticker GNLX.BOATS.

What is Genelux market cap?▼

Today Genelux has the market capitalization of 92.09M

When is the next Genelux earnings date?▼

Genelux is going to release the next earnings report on May 13, 2026.

What were Genelux earnings last quarter?▼

GNLX.BOATS earnings for the last quarter are -0.24 USD per share, whereas the estimation was -0.22 USD resulting in a -9.92% surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Genelux revenue for the last year?▼

Genelux revenue for the last year amounts to 16,000 USD.

What is Genelux net income for the last year?▼

GNLX.BOATS net income for the last year is -59.74M USD.

In which sector is Genelux located?▼

Genelux operates in the Other sector.

When did Genelux complete a stock split?▼

Genelux has not had any recent stock splits.